Promoter holding
64.27%
MC
Mody Chemi Pharma Limited - Due diligence report
A 360° intelligence report on Mody Chemi Pharma Limited: trust score, financial health, credit view, compliance, directors, growth and distr…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Mody Chemi Pharma Limited — 360° Intelligence Report
Generated from MCA filings & public records87/100
Trust Score
Low Risk
Mody Chemi Pharma Limited is assessed as Low Risk with a Trust Score of 87/100. Mody Chemi Pharma Limited is an active public limited indian non-government company incorporated in 2002, operating in the Chemicals and Materials sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.
Report generated on 03 Aug 2026 from the latest processed filings. Mody Chemi Pharma Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
87/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
93/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
80/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
95/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
45/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 95/100 Low Risk
- Liabilities ≈ 38% EBITDA - serviceable.
- Moderate gearing (D/E 1.42).
- Working-capital cover adequate.
- Profitable - internal accruals available.
- Externally credit-rated (SME).
Charges position: 2 open (11.78 cr) · 0 satisfied (-).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Hdfc Bank Limited | 2 | 48.0 cr |
Compliance Score: 93/100 Low Risk
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Litigation present in 1 court forum(s).
- 2 active GST registration(s).
Legal cases on record (1)
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| CHINTAN BHAVESH MODY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| BHAVESH NAVINCHANDRA MODY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| NIKUNJ BHAVESH MODY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| DHWANI CHINTAN MODY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VAIBHAV GANDHI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SWATI BHAVESH MODY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| NIDHI HARESH PAREKH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 7 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2025 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
7 allotment(s) · 2 transfer(s)
| Group entity | Relationship | % held |
|---|---|---|
| Alpha Kooltherm Private Limited | Subsidiary Company | 74.00% |
Key managerial personnel: BHAVESH NAVINCHANDRA MODY (Managing Director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 45 · Distress 65
Growth signals & trust indicators
EPFO headcount growing - hiring signal.
Operating for 24+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Profit declined two years in a row.
2 open charge(s) registered - assets are encumbered.
1 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence83/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment90/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 2 open charge(s) of 11.78 cr already registered.
- Compliance record supports lending.
Investor view68/100
Mixed indicators
Growth quality and scalability through an investor lens.
- 1 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
30 Sep 2022
Director ceased
VAIBHAV GANDHI
Director ceased
NIDHI HARESH PAREKH
06 Sep 2022
Director appointed
NIKUNJ BHAVESH MODY (Director)
31 Mar 2022
Share transfer (FY 2022)
300.00000000 shares to Dhwani Chintan Mody Jointly with Chintan Bhavesh Mody
Share transfer (FY 2022)
300.00000000 shares to Zeel Nikunj Mody jointly with Nikunj Bhavesh Mody
29 Mar 2022
Director appointed
VAIBHAV GANDHI (Director)
Director appointed
NIDHI HARESH PAREKH (Director)
10 Feb 2022
Securities allotted
9450 Equity Shares - 1.07 cr raised
23 Mar 2021
Securities allotted
364198 Equity Shares - 36.42 Lakh raised
Securities allotted
6780000 Preference Shares - 6.78 cr raised
16 Aug 2020
Director ceased
CHINTAN BHAVESH MODY
31 Dec 2018
Director ceased
DHWANI CHINTAN MODY
12 Feb 2018
Director appointed
DHWANI CHINTAN MODY (Director)
10
Key Observations
Auto-generated from the data aboveRevenue declined 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
7 active director(s) / partner(s); board looks stable and experienced.
2 active GST registration(s) indicate ongoing business operations.
Carries an external credit rating of SME from Crisil.
EPFO-registered employer - verifiable payroll history exists.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 7 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Paras Dyes & Chemicals Private Limited | U24100DL2010PTC207172 | New Delhi, Delhi, India |
| Zenith Drugs Limited | L24231MP2000PLC014465 | Depalpur, Madhya Pradesh, India |
| Kinvan Private Limited | U24100HP2020PTC011851 | Solan, Himachal Pradesh, India |
| Sadhana Nitro Chem | L24110MH1973PLC016698 | Mumbai, Maharashtra, India |
| Ultrafine Mineral & Admixtures Private Limited | U24100MH2020PTC338575 | Nagpur, Maharashtra, India |
| Star Hi Herbs | U01117KA2008PTC046084 | Bangalore, Karnataka, India |
| Lewens Labs Private Limited | U24233GJ2014PTC081091 | Bharuch, Gujarat, India |
| Maxwell Life Science Limited | U24230MH2004PLC146536 | Borivali West, Maharashtra, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Mody Chemi Pharma Limited before audits and certifications: compliance score 93/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Mody Chemi Pharma Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 95/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score 45/100, margin trends, ownership structure and peer set for Mody Chemi Pharma Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 87/100, distress signals and MSME payment-delay disclosures - know whether Mody Chemi Pharma Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Mody Chemi Pharma Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Mody Chemi Pharma Limited an active company?
Mody Chemi Pharma Limited has MCA status “Active” with a compliance score of 93/100 (Low Risk).
Is Mody Chemi Pharma Limited financially healthy?
Mody Chemi Pharma Limited has a Financial Health Score of 80/100 (Low Risk) based on its filed financial statements.
Should I do business with Mody Chemi Pharma Limited?
Its overall Trust Score is 87/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Mody Chemi Pharma Limited?
See the directors and ownership sections above for board and shareholding detail. 7 active director(s) are on record.
Does Mody Chemi Pharma Limited have loans or charges against its assets?
2 open charge(s) are registered against its assets.
Is Mody Chemi Pharma Limited up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 93/100 (Low Risk).
Is it risky to lend to Mody Chemi Pharma Limited?
Its Credit Risk Score is 95/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
